These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 9730698

  • 21. [Angiotensin converting enzyme gene polymorphism and type 2 diabetic nephropathy].
    Liao L, Lei MX, Chen HL.
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):553-6. PubMed ID: 15804059
    [Abstract] [Full Text] [Related]

  • 22. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
    Kimura H, Gejyo F, Suzuki Y, Suzuki S, Miyazaki R, Arakawa M.
    Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
    [Abstract] [Full Text] [Related]

  • 23. Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients.
    Arfa I, Abid A, Nouira S, Elloumi-Zghal H, Malouche D, Mannai I, Zorgati MM, Ben Alaya N, Rebai A, Zouari B, Ben Ammar S, Ben Rayana MC, Hmida S, Blousa-Chabchoub S, Abdelhak S.
    J Renin Angiotensin Aldosterone Syst; 2008 Mar; 9(1):32-6. PubMed ID: 18404607
    [Abstract] [Full Text] [Related]

  • 24. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM.
    Doi Y, Yoshizumi H, Yoshinari M, Iino K, Yamamoto M, Ichikawa K, Iwase M, Fujishima M.
    Diabetologia; 1996 Jan; 39(1):97-102. PubMed ID: 8720609
    [Abstract] [Full Text] [Related]

  • 25. [Angiotensin-converting enyme insertion/deletion polymorphism and blood pressure regulation in type 2 diabetic patients].
    Krajina-Andricević M, Zibar L, Glavas-Obrovac- L, Stefanić M, Avdicević M, Barbić J.
    Acta Med Croatica; 2011 Oct; 65 Suppl 3():14-9. PubMed ID: 23120809
    [Abstract] [Full Text] [Related]

  • 26. Association of the angiotensinogen M235T and angiotensin-converting enzyme insertion/deletion gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy.
    Eroglu Z, Cetinkalp S, Erdogan M, Kosova B, Karadeniz M, Kutukculer A, Gunduz C, Tetik A, Topcuoglu N, Ozgen AG, Tuzun M.
    J Diabetes Complications; 2008 Oct; 22(3):186-90. PubMed ID: 18413162
    [Abstract] [Full Text] [Related]

  • 27. Angiotensin converting enzyme gene polymorphism and glomerular filtration rate changes in type 2 diabetic patients.
    Araz M, Okan V, Celen Z, Aynacioglu S.
    Int J Clin Pract; 2002 Oct; 56(6):416-8. PubMed ID: 12166538
    [Abstract] [Full Text] [Related]

  • 28. [Association between ACE gene polymorphism and therapeutic responsiveness of ACEI in diabetic nephropathy].
    Wang L, Pan CY, Hu W.
    Zhonghua Yi Xue Za Zhi; 1998 May; 78(5):372-4. PubMed ID: 10923445
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control.
    Barnas U, Schmidt A, Illievich A, Kiener HP, Rabensteiner D, Kaider A, Prager R, Abrahamian H, Irsigler K, Mayer G.
    Diabetologia; 1997 Mar; 40(3):327-31. PubMed ID: 9084972
    [Abstract] [Full Text] [Related]

  • 31. Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus.
    Mizuiri S, Hemmi H, Inoue A, Yoshikawa H, Tanegashima M, Fushimi T, Ishigami M, Amagasaki Y, Ohara T, Shimatake H.
    Nephron; 1995 Mar; 70(4):455-9. PubMed ID: 7477652
    [Abstract] [Full Text] [Related]

  • 32. [The significance of deletion polymorphism in the ACE gene for progression of diabetic nephropathies treated with ACE inhibitors].
    Tarnow L, Parving HH, Jacobsen P, Rossing P, Lecerf L, Poirier O, Cambien F.
    Ugeskr Laeger; 1998 Aug 17; 160(34):4886-9. PubMed ID: 9741257
    [Abstract] [Full Text] [Related]

  • 33. Angiotensin-I-converting enzyme insertion/deletion polymorphism and high urinary albumin concentration in French Type 2 diabetes patients.
    Hadjadj S, Gallois Y, Alhenc-Gelas F, Chatellier G, Marre M, Genes N, Lievre M, Mann J, Menard J, Vasmant D, DIABHYCAR Study Group.
    Diabet Med; 2003 Aug 17; 20(8):677-82. PubMed ID: 12873298
    [Abstract] [Full Text] [Related]

  • 34. Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM.
    Penno G, Chaturvedi N, Talmud PJ, Cotroneo P, Manto A, Nannipieri M, Luong LA, Fuller JH.
    Diabetes; 1998 Sep 17; 47(9):1507-11. PubMed ID: 9726242
    [Abstract] [Full Text] [Related]

  • 35. Influence of insertion/deletion polymorphism in the ACE-I gene on the progression of diabetic glomerulopathy in type 1 diabetic patients with microalbuminuria.
    Rudberg S, Rasmussen LM, Bangstad HJ, Osterby R.
    Diabetes Care; 2000 Apr 17; 23(4):544-8. PubMed ID: 10857950
    [Abstract] [Full Text] [Related]

  • 36. Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM.
    Fujisawa T, Ikegami H, Shen GQ, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, Ueda H, Rakugi H, Higaki J.
    Diabetes Care; 1995 Jul 17; 18(7):983-5. PubMed ID: 7555560
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.